Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2

2(40.0%)

N/A

2(40.0%)

Phase 3

1(20.0%)

5Total

Phase 2(2)

N/A(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04303377Phase 2Withdrawn

Early Treatment With Evolocumab in Patients With ST-elevation Myocardial Infarction

Role: collaborator

NCT06514131Not ApplicableRecruiting

Water Hygiene Versus Waterless Hygiene Technology for Totally Dependent Hospitalized Patients

Role: collaborator

NCT05448092Unknown

Registry for Evaluation of Lumbar Arthrodesis Sagittal alignmEnt

Role: collaborator

NCT04214236Not ApplicableUnknown

CiNPT for Abdominoplasties in Post-bariatric Patients Study

Role: lead

NCT02848937Unknown

Calcium Mass Balance and Dialytic Efficiency of a New cITRate-containing and Acetate-free Dialysis flUidS: CITRUS Study

Role: lead

NCT01784549Phase 2Unknown

Customized Neoadjuvant Versus Standard Chemotherapy in NSCL Patients With Resectable Stage IIIA (N2)Disease

Role: collaborator

NCT01360346Phase 3Unknown

Enteral Versus Intravenous Sedation in Critically Ill High-risk ICU Patients

Role: collaborator

All 7 trials loaded